Owner BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

Inventors CIRILLO, Pier, F.; GOLDBERG, Daniel, R.; HAMMACH, Abdelhakim; MOSS, Neil; MUELLER, Kristen; REGAN, John, Robinson

Pub. Number AU-A-2002254302

PCT Pub. Number WO2002/083628

Priority 60/283,642 13.04.01 US

Filing date 21 March 2002

Wipo publication date 28 October 2002

C07C 275/40 Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

A61P 017/06 Drugs for dermatological disorders

A61P 019/02 Drugs for skeletal disorders

A61P 019/10 Drugs for skeletal disorders

C07C 311/08 Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07D 213/79 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/81 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 239/34 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 265/32 Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 309/36 Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

A61K 031/17 - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 031/18 - Sulfonamides

A61P 009/04 Drugs for disorders of the cardiovascular system